Physician profile
Crystal Dockery
NPI 1114347069
$3,781.51
in general payments reported to CMS, 2019-2025
25 companies · $16.68 in 2025
The $16.68 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,707 · 2020: $1,253 · 2021: $805 · 2025: $16.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $734.12 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.17 | 2019-2021 | |
| Glaxosmithkline, LLC. | $315.74 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $312.43 | 2019-2021 | |
| Lilly USA, LLC | $261.65 | 2019-2021 | |
| Pfizer INC. | $247.94 | 2019-2021 | |
| Abbvie INC. | $202.68 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.41 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.87 | 2019-2020 | |
| Novo Nordisk INC | $138.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $95.62 | 2019-2021 | |
| Astellas Pharma US INC | $90.41 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $88.24 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $88.20 | 2021 | |
| Eisai INC. | $87.96 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $86.91 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $74.86 | 2019-2020 | |
| Amarin Pharma, INC. | $67.75 | 2019-2020 | |
| Antares Pharma, INC. | $50.54 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $38.76 | 2019-2020 | |
| Allergan, INC. | $34.69 | 2019-2020 | |
| Abbott Laboratories | $17.06 | 2019 | |
| Bardy Diagnostics, INC. | $14.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.14 | 2020 | |
| Shire North American Group INC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Dockery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.